2,187 Results
Lupin secures NMPA approval for Oseltamivir oral suspension in China through a co-development partnership with Yabao Pharmaceuticals.
Pharma Now Editorial Team | May 22, 2026
Venus Remedies secures SFDA approval for Plerixafor, marking entry into GCC specialty oncology injectables and raising the bar on site qualification strategy.
Pharma Now Editorial Team | May 22, 2026
FDA approves Differin Epiduo for OTC use under NDA 220736, triggering labeling, validation, and packaging compliance obligations for manufacturers.
Pharma Now Editorial Team | May 22, 2026
CHMP issues positive opinion for Boehringer Ingelheim's nerandomilast in IPF and PPF, advancing EU approval for the first new fibrosis therapy in over a decade.
Pharma Now Editorial Team | May 22, 2026
CHMP backs oral Wegovy as EU's first GLP-1 obesity pill, triggering a solid-dose scale-up challenge for Novo Nordisk ahead of a 2026 ex-US launch.
Pharma Now Editorial Team | May 22, 2026
FDA approves Daiichi Sankyo's Datroway for metastatic TNBC under Project Orbis, with five international agencies still reviewing.
Pharma Now Editorial Team | May 22, 2026
FDA CDER cleared at least 13 first-time generics between October and December 2025, spanning diabetes, MS, respiratory, and injectable categories.
Pharma Now Editorial Team | May 22, 2026